Recurrent oedema of the uvula in a patient with chronic spontaneous urticaria successfully treated with omalizumab

Abstract

Uvula oedema is a condition characterized by a sensation of a foreign body in the oropharynx and difficulty to speak; sometimes, if associated with glottis oedema, difficulty to breathe and dysphonia are also present. Urticaria is a disease characterized by itching wheals on the skin, and sometimes angioedema. Chronic urticaria is spontaneous when the etiology is unknown. Chronic urticaria may be disabling and difficult to treat, with a negative impact on the patient’s quality of life. Omalizumab administration is suggested for refractory patients as add-on therapy to the antihistamines, in a third line. In Italy, omalizumab may be used for the treatment of spontaneous chronic urticaria in patients older than 12 years, refractory to antihistamines, with UAS >3 and UAS7 > 16. We describe a case of a 62-year-old woman had had recurring uvula oedema and chronic urticaria, not responder to antihistamines and oral corticosteroids. After 6 months of treatment with omalizumab and antihistamines, no urticaria recurrence was reported and no new episodes of angioedema had occurred. Our experience showed that omalizumab might be effective in patients with recurrent uvula oedema associated with urticaria.

KEYWORDS:

• Uvula oedema
• chronic spontaneous urticaria
• CSU
• omalizumab

Acknowledgements

Laura Brogelli, PhD, on behalf of Content Ed Net, provided editorial assistance for the preparation of this manuscript; this assistance was funded by Novartis Farma Italy.

Disclosure statement

The authors report no conflict of interest.

Funding

This supplement was funded by Novartis.